Aerosol Delivery of Surfactant Liposomes for Management of Pulmonary Fibrosis: An Approach Supporting Pulmonary Mechanics

Aerosol Delivery of Surfactant Liposomes for Management of Pulmonary Fibrosis: An Approach Supporting Pulmonary Mechanics

Excessive architectural re-modeling of tissues in pulmonary fibrosis due to proliferation of myofibroblasts and deposition of extracellular matrix adversely affects the elasticity of the alveoli and lung function. Progressively destructive chronic inflammatory disease, therefore, necessitates safe a...

Full description

Bibliographic Details
Main Authors:	Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Lenah S. Binmahfouz, Rana Bakur Bakhaidar, Nagaraja Sreeharsha, Anroop B. Nair, Chandramouli Ramnarayanan
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Pharmaceutics
Subjects:	pulmonary fibrosis naringin bleomycin liposomes aerosol
Online Access:	https://www.mdpi.com/1999-4923/13/11/1851

Similar Items

Lung Targeted Lipopolymeric Microspheres of Dexamethasone for the Treatment of ARDS
by: Sabna Kotta, et al.
Published: (2021-08-01)

Progress in Polymeric Micelles for Drug Delivery Applications
by: Sabna Kotta, et al.
Published: (2022-08-01)

Preparation and physicochemical characterization of N-succinyl chitosan-coated liposomes for oral delivery of grape seed extract and evaluation of its effect on pulmonary fibrosis induced by bleomycin in rats
by: Neda Bavarsad, et al.
Published: (2023-10-01)

Gelatin Methacryloyl (GelMA) Nanocomposite Hydrogels Embedding Bioactive Naringin Liposomes
by: Kamil Elkhoury, et al.
Published: (2020-12-01)

Thermosensitive Hydrogels Loaded with Resveratrol Nanoemulsion: Formulation Optimization by Central Composite Design and Evaluation in MCF-7 Human Breast Cancer Cell Lines
by: Sabna Kotta, et al.
Published: (2022-07-01)

Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
by: Sabna Kotta, et al.
Published: (2020-11-01)

Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics
by: Yaqeen Nadheer Al Badri, et al.
Published: (2023-01-01)

Saffron Protection against Bleomycin-Induced Pulmonary Fibrosis in Rats
by: Mehrzad Bahtouee, et al.
Published: (2017-11-01)

Improvement of Pulmonary Photodynamic Therapy: Nebulisation of Curcumin-Loaded Tetraether Liposomes
by: Jennifer Lehmann, et al.
Published: (2021-08-01)

The Effect of Methanol Extract of Fennel on Bleomycin-Induced Pulmonary Fibrosis in Rats
by: Mitra Samareh-Fekri, et al.
Published: (2015-12-01)

Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects
by: Shaimaa M. Badr-Eldin, et al.
Published: (2022-07-01)

Exploring the Potential of Carbon Dots to Combat COVID-19
by: Sabna Kotta, et al.
Published: (2020-12-01)

Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer
by: Hibah M. Aldawsari, et al.
Published: (2022-04-01)

Potential Therapeutic Uses of Thalidomide for Pulmonary Fibrosis
by: Niloofar Rashidpour, et al.
Published: (2023-07-01)

Ion-Triggered In Situ Gelling Nanoemulgel as a Platform for Nose-to-Brain Delivery of Small Lipophilic Molecules
by: Sreeharsha Nagaraja, et al.
Published: (2021-08-01)

Pulmonary cytotoxicity induced by bleomycin and methotrexate
by: Zh, V, Sheykh, et al.
Published: (2016-03-01)

Development and evaluation of quercetin enriched bentonite-reinforced starch-gelatin based bioplastic with antimicrobial property
by: Hibah Mubarak Aldawsari, et al.
Published: (2023-12-01)

High‐Resolution Transthoracic Echocardiography Accurately Detects Pulmonary Arterial Pressure and Decreased Right Ventricular Contractility in a Mouse Model of Pulmonary Fibrosis and Secondary Pulmonary Hypertension
by: Thomas S. Hansen, et al.
Published: (2022-12-01)

Naringin–Dextrin Nanocomposite Abates Diethylnitrosamine/Acetylaminofluorene-Induced Lung Carcinogenesis by Modulating Oxidative Stress, Inflammation, Apoptosis, and Cell Proliferation
by: Eman E. Mohamed, et al.
Published: (2023-10-01)

Alpinetin alleviates bleomycin-induced pulmonary fibrosis in mice
by: SI Changxing, DING Yanyan, YIN Fengxian
Published: (2023-12-01)

Pulmonary toxicity induced by the use of bleomycin in patients with germ cell testicular tumors
by: Nikolai A. Ognerubov, et al.
Published: (2022-05-01)

Effect of 0.25 ppm Ozone exposure on pulmonary damage induced by bleomycin
by: MANUEL OYARZÚN, et al.
Published: (2005-01-01)

Potential Protective Effects of Naringin on Oculo-Pulmonary Injury Induced by PM10 (Wood Smoke) Exposure by Modulation of Oxidative Damage and Acetylcholine Esterase Activity in a Rat Model
by: Jacob K. Akintunde, PhD, et al.
Published: (2020-01-01)

Composition Influence on Pulmonary Delivery of Rifampicin Liposomes
by: Maria Letizia Manca, et al.
Published: (2012-11-01)

Liposomes : from physics to applications /
by: 223345 Lasic, D. D.
Published: (1993)

Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes
by: Hanaa Wanas, et al.
Published: (2023-05-01)

Fish Oil Nanoemulsion Supplementation Attenuates Bleomycin-Induced Pulmonary Fibrosis BALB/c Mice
by: Danielle Galdino de Souza, et al.
Published: (2022-05-01)

Protective Effects of Hydroalcoholic Extract of Hypericum Perforatum Against Bleomycin-Induced Pulmonary Fibrosis in Rats
by: E Ebrahimi Naghani, et al.
Published: (2016-01-01)

Carboxymethyl Chitosan Modified Oxymatrine Liposomes for the Alleviation of Emphysema in Mice via Pulmonary Administration
by: Jianqing Peng, et al.
Published: (2022-06-01)

Curcumin as a promising treatment for pulmonary fibrosis: Mechanism and therapeutic potential
by: Meigui You, et al.
Published: (2024-03-01)

A case of bleomycin-induced lung toxicity
by: Cuneyt Tetikkurt, et al.
Published: (2018-11-01)

Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury
by: Badr Alzahrani, et al.
Published: (2022-03-01)

Liposomes as Drug Carriers: Classification, Preparation Methods, and Medicinal Use
by: N. I. Burdaev, et al.
Published: (2023-07-01)

What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
by: Hanieh Abbasi, et al.
Published: (2023-01-01)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
by: S. Chennakesavulu, et al.
Published: (2018-01-01)

Engineering of Stimulus-Responsive Pirfenidone Liposomes for Pulmonary Delivery During Treatment of Idiopathic Pulmonary Fibrosis
by: Meishan Han, et al.
Published: (2022-04-01)

PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model
by: Xichun Qin, et al.
Published: (2022-04-01)

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
by: Yuko Ishida, et al.
Published: (2023-02-01)

Liposom daripada koko /
by: 430367 Rohaizah Alwi
Published: (2000)

Liposome-mediated transfection /
by: 347843 Whitt, Michael, et al.